相关实验视频

Updated: Jul 5, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

免疫细胞和相关的细胞因子在扩大心肌病的扩大心肌病

Jingdi Zhang¹, Linlin Cheng¹, Zhan Li¹

¹Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|January 19, 2024

概括

扩张性心肌病 (DCM) 的发展涉及免疫细胞和炎症. 了解这种免疫病原发生可能会揭示心力衰竭的新生物标志物和治疗方法.

科学领域:

心脏病学心脏病学
免疫学免疫学免疫学
病变的发生和发病.

背景情况:

扩张性心肌病 (DCM) 是一种心肌疾病,其特点是心脏结构和功能功能障碍.
DCM增加了心力衰竭 (HF) 的风险,并涉及复杂的潜在病因.
免疫细胞激活和炎症级联越来越多地被认为是DCM病变发生的关键因素.

研究的目的:

审查免疫细胞和细胞因子在DCM病变发生中的作用.
探索潜在的免疫疗法策略来治疗DCM.

主要方法:

对DCM免疫病原发生学研究的文献综述.
对特定免疫细胞和细胞因子参与的分析.
检查当前和新兴的免疫疗法方法.

主要成果:

免疫细胞和炎症调解剂对心肌损伤和DCM重塑有显著的贡献.
异常的免疫系统激活导致DCM持续的炎症.
特定的细胞因子与DCM的进展有关.

结论:

免疫反应是DCM发展和进展的核心.
准免疫路径为DCM提供了潜在的治疗途径.
对DCM免疫病原发生的进一步研究可以确定新的生物标志物和治疗方法.

关键词:

细胞因子 (cytokines) 是一种细胞因子.扩展性心肌病变性是指扩展性心肌病变性.免疫细胞是免疫细胞.免疫疗法策略免疫疗法策略病变的发生和发病.

更多相关视频

Isolation and Identification of Extravascular Immune Cells of the Heart

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

相关概念视频

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...